A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages.
about
Ensuring transmission through dynamic host environments: host-pathogen interactions in Plasmodium sexual developmentCharacterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccineStrategies & recent development of transmission-blocking vaccines against Plasmodium falciparumTransmission-blocking strategies: the roadmap from laboratory bench to the communityConstruct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccineBaculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants.Recent advances in recombinant protein-based malaria vaccines.Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45.Progress and prospects for blood-stage malaria vaccinesSafety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study.The GMZ2 malaria vaccine: from concept to efficacy in humans.Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates.Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine.The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle.Associations Between Helminth Infections, Plasmodium falciparum Parasite Carriage and Antibody Responses to Sexual and Asexual Stage Malarial Antigens.The stage-specific in vitro efficacy of a malaria antigen cocktail provides valuable insights into the development of effective multi-stage vaccines.Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.Phase 3 trial with the RTS,S/AS01 malaria vaccine shows protection against clinical and severe malaria in infants and children in Africa.Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana.Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite.Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission.Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.[Profiles of IgG responses against CSP, GLURP and LSA-3NR2 in urban malaria (Dakar): relations with haemoglobin levels and parasite densities].Assessment of the quality and quantity of naturally induced antibody responses to EBA175RIII-V in Ghanaian children living in two communities with varying malaria transmission patterns.Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum.Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibodySafety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAPStructural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45Functional Conservation of P48/45 Proteins in the Transmission Stages of (Human Malaria Parasite) and . (Murine Malaria Parasite)
P2860
Q27007534-C81B4B52-7B40-4DE0-A77B-3EF38511EB7AQ27974539-6F6414B6-DC8D-4835-BA75-F286FA2F32FEQ28072195-1FF3E38F-2DBF-4465-8D30-7F36500DAF67Q28078982-0BD05C71-0D46-4354-AC6B-5941EA8DC01EQ33750638-67B55C9E-C0F2-448F-8925-2F4E450BAC01Q34298647-F581673C-1253-4C93-A78C-7B3FC925337BQ35718341-D14506DA-916F-4065-9577-2248940B3582Q36082968-0AEF34B9-DC8B-48BF-98DF-1893F247C098Q36178611-CC11B199-F100-4E58-ABC8-7BA26E069F78Q36267184-CC635CB5-0048-4A2C-B8F2-551A79431600Q36394182-FC3064CD-0476-4A98-B3C1-1D3F2EA82040Q36889732-99C08723-3E2D-49D1-A73A-161ADAA8EE89Q37025030-7650A96F-0FEB-4AC5-ABF6-E9DDC2A6E936Q37265801-185D7377-717D-4DAA-A16B-C523C95B2DACQ38658724-B41804AF-D82D-47AE-9A43-3C3EF8ABE311Q38672088-8B0D9D73-35E2-465A-A2D9-6C424CE422FBQ38775588-09C8AC5A-C716-41E6-926A-DFFA32401491Q38789240-31309125-4EEF-42FA-82B9-9C53C4B522D4Q38882835-43991C7F-6AA6-4B6A-92D8-95FD5CA6C3ACQ39013988-CA86060A-5FDA-4C79-B818-8F9CA29A7B97Q39141585-71E0042B-EA14-4271-8451-FF41D9D0CCA9Q39511718-5D530886-7E69-4B78-8EF9-A23966F52579Q40110842-45040F42-CAB3-4A0C-B57F-66CEAA5E9279Q40159945-10919177-BE7D-4A10-A599-D733E7C0FE12Q44169831-C026991B-0B63-4E25-AD9F-DE38B3EF3580Q44169982-CD2E9948-4FD1-406E-9003-47A49A0CC84EQ46299460-3C793396-71E8-4154-AB20-2C448F396191Q47347281-60C46545-8C88-4134-9240-ED6329E05C03Q49732059-D5322108-8FA9-4CF0-835A-72B46A4E3B53Q52606714-751A06A8-6382-4504-9A68-2AFF57117519Q57154118-C000F9F3-93F3-4DBC-B112-5576B42BEAA9Q57480738-9774EAEB-CFDC-4B95-AA3F-8D3AB7710A34Q58115505-4497CC0F-E6ED-4100-9567-4436473E3EE6Q58765365-3D7E1AD6-90ED-4EA5-B168-0BF7D98D236E
P2860
A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A multi-stage malaria vaccine ...... al parasite life-cycle stages.
@en
A multi-stage malaria vaccine ...... al parasite life-cycle stages.
@nl
type
label
A multi-stage malaria vaccine ...... al parasite life-cycle stages.
@en
A multi-stage malaria vaccine ...... al parasite life-cycle stages.
@nl
prefLabel
A multi-stage malaria vaccine ...... al parasite life-cycle stages.
@en
A multi-stage malaria vaccine ...... al parasite life-cycle stages.
@nl
P2093
P50
P1433
P1476
A multi-stage malaria vaccine ...... al parasite life-cycle stages.
@en
P2093
Bright Adu
Gorm Andersen
Linda Amoah
Michael Christiansen
Régis Wendpayangde Tiendrebeogo
Sophie Jones
Theo Arens
P304
P356
10.1016/J.VACCINE.2014.03.020
P407
P50
P577
2014-03-21T00:00:00Z